Dilshat Djumanov, Director of Data Science at Richmond Pharmacology explores how GDPR is central to protecting private information. From clinical research to patient monitoring, the collection and sharing of data is key, as outlined by Dilshat Djumanov, Director of Data Science at Richmond Pharmacology. In their PM Live article published today, Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry. The post Brexit control of critical data and the ability to share information adds to the complexity with the UK planning its own reforms under the Data Reform Bill.

These regulatory changes, and other in the various frameworks around the world, are helping the integration of data management tools and realise the potential benefit for both industry and patients of better data-sharing tools. Unlocking the next generation of data sharing, processing and visualisation in clinical trials will be the next great frontier in pharmaceuticals. Medical privacy has been at the core of trial participation for a long time and the clinical research industry is perhaps the most advanced in understanding how to safely handle sensitive personal data.

Latest news

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Unlocking the potential of data sharing

January 4, 2023
Dilshat Djumonov explores how GDPR is central to protecting private information while presenting unique challenges to the pharmaceutical clinical trials industry.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event